Nom du produit:4-bromo-5-(cyclopropylmethyl)-1-methyl-1H-pyrazole

IUPAC Name:4-bromo-5-(cyclopropylmethyl)-1-methyl-1H-pyrazole

CAS:2079069-45-5
Formule moléculaire:C8H11BrN2
Pureté:95%+
Numéro de catalogue:CM423884
Poids moléculaire:215.09

Unité d'emballage Stock disponible Prix($) Quantité
CM423884-100mg 3-4 Weeks IJȃȃ
CM423884-250mg 3-4 Weeks ƥIJƿ
CM423884-1g 4-5 Weeks ƓȃŹ
CM423884-5g 6-7 Weeks IJƥǤŗ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:2079069-45-5
Formule moléculaire:C8H11BrN2
Point de fusion:-
Code SMILES:CN1N=CC(Br)=C1CC1CC1
Densité:
Numéro de catalogue:CM423884
Poids moléculaire:215.09
Point d'ébullition:
N° Mdl:MFCD31652575
Stockage:

Category Infos

Pyrazoles
Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.
Pyrazone
Custom pyrazone for customers from all over the world are our main business.

Column Infos

BTX-A51
Edgewood Oncology announced that the first two patients with metastatic breast cancer were treated with BTX-A51, a multi-specific kinase inhibitor of casein kinase 1 alpha (CK1α) and cyclin-dependent kinases 7 and 9 (CDK7 and CDK9), that synergistically targets master regulators of cancer. BTX-A51 is being evaluated in a Phase 2a study for the treatment of estrogen receptor positive / human epidermal growth factor receptor 2 negative (ER+/HER2-) metastatic breast cancer with and without GATA binding protein 3 (GATA3) mutations.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.

Related Products